U.S., July 16 -- ClinicalTrials.gov registry received information related to the study (NCT07706335) titled 'Insulin Resistance and Its Association With no Reflow Phenomenon After Primary PCI in Type II Diabetic STEMI Patients.' on July 11.
Brief Summary: To investigate the relationship between the TyG index, coronary lesion complexity assessed by the SYNTAX score, and the development of the no-reflow phenomenon in STEMI patients with T2DM.
Study Start Date: Aug. 01
Study Type: OBSERVATIONAL
Condition:
STEMI
No-Reflow Phenomenon
Diabetic Patient
Intervention:
PROCEDURE: PCI
All eligible patients presenting with ST-segment elevation myocardial infarction (STEMI) will undergo primary percutaneous coronary intervention (PPCI)
Recruitm...